This test screens for 50 cancers - but whether Medicare and other health insurers will cover it hinges on FDA approval
Abbott Laboratories ABL
News
Abbott to Pay $385 Million to Resolve Baby Formula Contamination Claims
Abbott Receives FDA Approval for Device to Treat Abnormal Heart Rhythm
Abbott to Pay $670 Million to Settle Baby-Formula Litigation
Abbott Laboratories Up Over 11%, on Pace for Largest Percent Increase Since July 2002 — Data Talk
Abbott Laboratories 2Q Sales Rise on Diagnostics Growth
A new blood test can help detect colon cancer, but it's not as good as the test you hate to take
Abbott Laboratories on Pace for Largest Percent Increase Since April 2023 — Data Talk
MiniMed Shares Rise on 4Q Sales, Abbott Partnership Expansion
Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt 1Q Sales — Update
Abbott Laboratories On Pace for Lowest Close Since November 2023 — Data Talk
Abbott Laboratories Cuts Outlook, Narrows 1Q Profit
This beaten-down sector could offer you a ripe -2-
This beaten-down sector could offer you a ripe investment opportunity
Abbott Laboratories Raised Prices, Prompting Sales Slump — Update
Abbott Lab Down Over 7%, On Pace For Largest Percent Decrease Since July 2025 — Data Talk
Abbott Laboratories 4Q Sales Grow, Outlook Underwhelms
Boston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clots
Abbott Gets FDA Approval for Volt Medical Device to Treat Arrhythmia
Abbott Labs Maintains Royal Dividend Status With 6.8% Increase
United States